Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neogia was a French medical technology startup that developed wearable devices for monitoring sleep disorders, specifically obstructive sleep apnea. The company's primary innovation was the Motio HW, a smart ring equipped with sensors to measure blood oxygen levels, heart rate, and physical activity. Designed as a user-friendly alternative to bulky sleep lab equipment, the device aimed to facilitate home-based diagnosis and long-term monitoring. The technology utilized proprietary algorithms to analyze physiological data and provide insights into sleep quality and respiratory events. Despite early promise and participation in major tech events like CES, the company faced financial challenges and entered judicial liquidation in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neogia.